• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cel-Sci Corporation Common Stock (NY:CVM)

1.210 -0.020 (-1.63%)
Streaming Delayed Price Updated: 1:06 PM EDT, Jul 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 63,557
Open 1.240
Bid (Size) 1.210 (600)
Ask (Size) 1.220 (200)
Prev. Close 1.230
Today's Range 1.190 - 1.240
52wk Range 0.8900 - 13.48
Shares Outstanding 8,457,967
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer
July 13, 2026
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
June 24, 2026
From CEL-SCI Corporation
Via Business Wire

Performance

YTD
-76.5%
-76.5%
1 Month
+19.8%
+19.8%
3 Month
-63.8%
-63.8%
6 Month
-77.0%
-77.0%
1 Year
-77.0%
-77.0%

More News

Read More
News headline image
CEL-SCI Announces Closing of Offering
June 16, 2026
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
June 16, 2026
From CEL-SCI Corporation
Via Business Wire
Why DID CVM Shares Rally Over 7% Today? ↗
January 26, 2026
Via Stocktwits
Retail Buzz Builds Around Cel-Sci Stock Ahead Of Saudi Ruling On Cancer Drug Multikine ↗
October 15, 2025
Via Stocktwits
News headline image
CEL-SCI Corporation Announces Pricing of Offering
June 14, 2026
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia
June 12, 2026
From CEL-SCI Corporation
Via Business Wire
InvestorNewsBreaks – CEL-SCI Corporation (NYSE American: CVM) Closes $7.2 Million Public Offering
May 19, 2026
Via Investor Brand Network
News headline image
CEL-SCI Reports Fiscal Second Quarter 2026 Results
May 18, 2026
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Announces Closing of Public Offering
May 13, 2026
From CEL-SCI Corporation
Via Business Wire
Tuesday's session: top gainers and losers ↗
May 12, 2026
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
May 12, 2026
Via Chartmill
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
May 12, 2026
Via Chartmill
News headline image
CEL-SCI Corporation Announces Pricing of Public Offering
May 11, 2026
From CEL-SCI Corporation
Via Business Wire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
May 11, 2026
Via Chartmill
News headline image
CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
May 11, 2026
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Reports Fiscal First Quarter 2026 Results
February 18, 2026
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Reports Fiscal 2025 Results
December 29, 2025
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Announces Closing of $10 Million Public Offering
August 29, 2025
From CEL-SCI Corporation
Via Business Wire
News headline image
Thursday's session: top gainers and losers ↗
August 28, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
August 28, 2025
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
August 28, 2025
Via Chartmill
News headline image
The market is filled with gapping stocks in Thursday's session. ↗
August 28, 2025
Via Chartmill
News headline image
Wondering what's happening in today's pre-market session? ↗
August 28, 2025
Via Chartmill

Frequently Asked Questions

Is Cel-Sci Corporation Common Stock publicly traded?
Yes, Cel-Sci Corporation Common Stock is publicly traded.
What exchange does Cel-Sci Corporation Common Stock trade on?
Cel-Sci Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Cel-Sci Corporation Common Stock?
The ticker symbol for Cel-Sci Corporation Common Stock is CVM on the New York Stock Exchange
What is the current price of Cel-Sci Corporation Common Stock?
The current price of Cel-Sci Corporation Common Stock is 1.210
When was Cel-Sci Corporation Common Stock last traded?
The last trade of Cel-Sci Corporation Common Stock was at 07/23/26 01:06 PM ET
What is the market capitalization of Cel-Sci Corporation Common Stock?
The market capitalization of Cel-Sci Corporation Common Stock is 10.23M
How many shares of Cel-Sci Corporation Common Stock are outstanding?
Cel-Sci Corporation Common Stock has 10M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap